Mirae Asset Global Investments
LEGN icon

Mirae Asset Global Investments’s Legend Biotech LEGN Stock Holding History

Mirae Asset Global Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Sell
7,485
-3,638
-33% -$98.1K ﹤0.01% 1108
2026
Q1 		$201K Buy
11,123
+12
+0.1% +$229 ﹤0.01% 1070
2025
Q4 		$242K Sell
11,111
-1,101
-9% -$31.5K ﹤0.01% 1117
2025
Q3 		$398K Sell
12,212
-2,725
-18% -$101K ﹤0.01% 1022
2025
Q2 		$530K Sell
14,937
-989,397
-99% -$32.1M ﹤0.01% 935
2025
Q1 		$216K Buy
1,004,334
+989,635
+6,733% +$35.5M ﹤0.01% 1036
2024
Q4 		$479K Sell
14,699
-13,850
-49% -$574K ﹤0.01% 953
2024
Q3 		$1.39M Sell
28,549
-13,151
-32% -$701K 0.01% 735
2024
Q2 		$1.85M Buy
41,700
+15,749
+61% +$727K 0.01% 597
2024
Q1 		$1.4M Sell
25,951
-34,541
-57% -$2.08M ﹤0.01% 1361
2023
Q4 		$3.64M Buy
+60,492
New +$3.83M 0.01% 1009

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Mirae Asset Global Investments's LEGN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Legend Biotech (LEGN) stake by 33% in Q2 2026, selling an estimated $98.1K and leaving 7,485 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Mirae Asset Global Investments first reported a position in LEGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.64M in Q4 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Mirae Asset Global Investments held 7,485 shares of Legend Biotech worth $216K as of Q2 2026.
  • Mirae Asset Global Investments sold 3,638 Legend Biotech shares in Q2 2026, an estimated $98.1K.
  • Legend Biotech made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1108 holding.
  • Mirae Asset Global Investments first reported a position in Legend Biotech in Q4 2023 and has held it in 11 quarters since.
  • Mirae Asset Global Investments's Legend Biotech position peaked at $3.64M in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.